Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Similar articles for PubMed (Select 23986522)

1.

Genetic deletion of growth differentiation factor 15 augments renal damage in both type 1 and type 2 models of diabetes.

Mazagova M, Buikema H, van Buiten A, Duin M, Goris M, Sandovici M, Henning RH, Deelman LE.

Am J Physiol Renal Physiol. 2013 Nov 1;305(9):F1249-64. doi: 10.1152/ajprenal.00387.2013. Epub 2013 Aug 28.

2.

Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.

Elmarakby AA, Faulkner J, Al-Shabrawey M, Wang MH, Maddipati KR, Imig JD.

Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1307-17. doi: 10.1152/ajpregu.00759.2010. Epub 2011 Aug 10.

3.

Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.

Guo C, Martinez-Vasquez D, Mendez GP, Toniolo MF, Yao TM, Oestreicher EM, Kikuchi T, Lapointe N, Pojoga L, Williams GH, Ricchiuti V, Adler GK.

Endocrinology. 2006 Nov;147(11):5363-73. Epub 2006 Aug 10.

PMID:
16901964
4.

Growth differentiation factor 15 impairs aortic contractile and relaxing function through altered caveolar signaling of the endothelium.

Mazagova M, Buikema H, Landheer SW, Vavrinec P, Buiten Av, Henning RH, Deelman LE.

Am J Physiol Heart Circ Physiol. 2013 Mar 1;304(5):H709-18. doi: 10.1152/ajpheart.00543.2012. Epub 2012 Dec 21.

5.

Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.

Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB.

Am J Physiol Renal Physiol. 2009 Sep;297(3):F729-39. doi: 10.1152/ajprenal.00086.2009. Epub 2009 Jun 24.

6.
7.

Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy.

Wang S, Denichilo M, Brubaker C, Hirschberg R.

Kidney Int. 2001 Jul;60(1):96-105.

8.

Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.

Shahni R, Gnudi L, King A, Jones P, Malik AN.

Diabetologia. 2012 Mar;55(3):825-34. doi: 10.1007/s00125-011-2373-4. Epub 2011 Nov 18.

PMID:
22095236
9.

Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice.

Shiota A, Yamamoto K, Ohishi M, Tatara Y, Ohnishi M, Maekawa Y, Iwamoto Y, Takeda M, Rakugi H.

Hypertens Res. 2010 Apr;33(4):298-307. doi: 10.1038/hr.2009.231. Epub 2010 Feb 26.

PMID:
20186149
10.

Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.

Kuwabara T, Mori K, Mukoyama M, Kasahara M, Yokoi H, Saito Y, Ogawa Y, Imamaki H, Kawanishi T, Ishii A, Koga K, Mori KP, Kato Y, Sugawara A, Nakao K.

Diabetologia. 2012 Aug;55(8):2256-66. doi: 10.1007/s00125-012-2578-1. Epub 2012 May 19.

PMID:
22610400
11.
12.

Deletion of p66Shc longevity gene protects against experimental diabetic glomerulopathy by preventing diabetes-induced oxidative stress.

Menini S, Amadio L, Oddi G, Ricci C, Pesce C, Pugliese F, Giorgio M, Migliaccio E, Pelicci P, Iacobini C, Pugliese G.

Diabetes. 2006 Jun;55(6):1642-50.

13.

The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.

Chen HY, Huang XR, Wang W, Li JH, Heuchel RL, Chung AC, Lan HY.

Diabetes. 2011 Feb;60(2):590-601. doi: 10.2337/db10-0403. Epub 2010 Oct 27.

14.

Acceleration of diabetic renal injury in the superoxide dismutase knockout mouse: effects of tempol.

DeRubertis FR, Craven PA, Melhem MF.

Metabolism. 2007 Sep;56(9):1256-64.

PMID:
17697870
15.

p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.

Wolf G, Schanze A, Stahl RA, Shankland SJ, Amann K.

Kidney Int. 2005 Oct;68(4):1583-9.

PMID:
16164635
16.

Role of Nox2 in diabetic kidney disease.

You YH, Okada S, Ly S, Jandeleit-Dahm K, Barit D, Namikoshi T, Sharma K.

Am J Physiol Renal Physiol. 2013 Apr 1;304(7):F840-8. doi: 10.1152/ajprenal.00511.2012. Epub 2013 Feb 6.

17.

Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: role of advanced glycation end products.

Lassila M, Seah KK, Allen TJ, Thallas V, Thomas MC, Candido R, Burns WC, Forbes JM, Calkin AC, Cooper ME, Jandeleit-Dahm KA.

J Am Soc Nephrol. 2004 Aug;15(8):2125-38.

18.

Kidney expression of glutathione peroxidase-1 is not protective against streptozotocin-induced diabetic nephropathy.

de Haan JB, Stefanovic N, Nikolic-Paterson D, Scurr LL, Croft KD, Mori TA, Hertzog P, Kola I, Atkins RC, Tesch GH.

Am J Physiol Renal Physiol. 2005 Sep;289(3):F544-51. Epub 2005 Apr 12.

19.

Mice lacking Smad3 are protected against streptozotocin-induced diabetic glomerulopathy.

Fujimoto M, Maezawa Y, Yokote K, Joh K, Kobayashi K, Kawamura H, Nishimura M, Roberts AB, Saito Y, Mori S.

Biochem Biophys Res Commun. 2003 Jun 13;305(4):1002-7.

PMID:
12767930
20.

Allelic depletion of grem1 attenuates diabetic kidney disease.

Roxburgh SA, Kattla JJ, Curran SP, O'Meara YM, Pollock CA, Goldschmeding R, Godson C, Martin F, Brazil DP.

Diabetes. 2009 Jul;58(7):1641-50. doi: 10.2337/db08-1365. Epub 2009 Apr 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk